Article

4 Recommendations for Treating Fatigue in RA

There are many treatments and strategies to address fatigue in rheumatoid arthritis (RA) patients, but no one approach works for all patients. In this slideshow, we highlight key takeaways from a recent review that highlights key strategies for treating fatigue in RA.

Most rheumatoid arthritis (RA) patients will experience bouts of fatigue throughout the course of their disease. It can range from mild to severe and for some patients, it can be debilitating. For RA patients with fatigue, there is no clear path to recovery, experts say.

One analysis cited in a review published in RMD Open last month stated that fatigue is usually an issue for most patients, even those with low disease activity. At least 40% of RA patients will experience severe fatigue at some point, wrote Janet E. Pope, M.D., MPH, FRCPC, a professor of medicine in rheumatology at the University of Western Ontario.

Fatigue is most often associated with chronic pain, which can lead to poor sleep and depression. It is also most prevalent among patients who are obese or have multiple comorbidities.

There are many treatments and strategies to address fatigue in rheumatoid arthritis patients, but no one approach works for all patients. For some patients, fatigue is a constant. To date, according to the review, the best treatments remain resolving chronic pain, improving sleep, exercise, and addressing mental health issues.

In this slideshow, we highlight key takeaways from the review.

REFERENCE

Pope JE. “Management of Fatigue in Rheumatoid Arthritis.” RMD Open. May 2020. doi: 10.1136/rmdopen-2019-001084

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.